menu search

Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference

Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a Novel Immuno-Oncology (IO) panel discussion at the Cowen 43rd Annual Health Care Conference taking place at the Marriott […] The post Surface Oncology to Participate in the Cowen 43rd Annual Health Care Confe... Read More
Posted: Feb 28 2023, 21:15
Author Name: forextv
Views: 082266

Search within

Pages Search Results: